BioLamina is a Swedish biotechnology company with a global presence. We offer an expansive portfolio of defined and xeno-free human recombinant laminin proteins for a variety of applications, including reliable expansion of human pluripotent stem cells and differentiation and maintenance of different specialized cell types, such as hepatocytes, cardiomyocytes and neural cells. By providing the cells with their biologically relevant matrix proteins, you can get more consistent cellular responses, improve the differentiation potential, and keep adult cells mature for a significantly longer time in culture than has previously been feasible. The impact of our laminin matrices on the advances in cell based research and therapy have been published in many high-impact journals. 


« Go Back

Supporting Publication